Lofepramine: a return to tricyclic antidepressives
Lofepramine (Gamanil - E.Merck) is a new tricyclic antidepressive, a precursor of desipramine (desmethylimipramine). Its development aimed to retain the efficacy of standard tricyclics with a more rapid onset of action and fewer anticholinergic effects. Has this been achieved?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.